Greetings from Australia. I have just got off the phone with Professor G Randall at the Chicago Institute for Disease Control and he can confirm without hesitation the following. Cannabidiol from the cannabis plant has potential to prevent and inhibit SARS-CoV-2 infection. A recent and intensive study shows that the Cannabidiol compound produced can interrupt the completion of the genetic sequence that allows the Spike Protein receptors in SARS-CoV-2 to bind to a human cell and replicate itself to infect and overrun the natural flow of proteins and Amino Acids in the body grid. This now creates a greater new incentive supported by Science for growers to up their game and produce more high quality CBD oils for healing and now disease prevention. I have had CV19 twice and in both cases underwent a strict healing regime of Ivermectin, Selenium extract, Hydroxylchloroquine and home infused CBD oils and tinctures and was able to reverse all symptoms and effects within 48 hours of holistic treatment.
Details below.
January 2022
The rapid spread of COVID-19 underscores the need for new treatments. Here we report that cannabidiol (CBD), a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its metabolite, 7-OH-CBD, but not congeneric cannabinoids, potently block SARS-CoV-2 replication in lung epithelial cells. CBD acts after cellular infection,5 inhibiting viral gene expression and reversing many effects of SARS-CoV-2 on host gene transcription. CBD induces interferon expression and up-regulates its antiviral signaling pathway. A cohort of human patients previously taking CBD had significantly lower SARS-CoV-2 infection incidence of up to an order of magnitude relative to matched pairs or the general population. This study highlights CBD, and its active metabolite, 7-OH-CBD, as10 potential preventative agents and therapeutic treatments for SARS-CoV-2 at early stages of infection
Indica females, 2nd generation
January 2022
The rapid spread of COVID-19 underscores the need for new treatments. Here we report that cannabidiol (CBD), a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its metabolite, 7-OH-CBD, but not congeneric cannabinoids, potently block SARS-CoV-2 replication in lung epithelial cells. CBD acts after cellular infection,5 inhibiting viral gene expression and reversing many effects of SARS-CoV-2 on host gene transcription. CBD induces interferon expression and up-regulates its antiviral signaling pathway. A cohort of human patients previously taking CBD had significantly lower SARS-CoV-2 infection incidence of up to an order of magnitude relative to matched pairs or the general population. This study highlights CBD, and its active metabolite, 7-OH-CBD, as10 potential preventative agents and therapeutic treatments for SARS-CoV-2 at early stages of infection
Indica females, 2nd generation
